We use cookies to ensure that we give you the best experience on our website. It will mean you have agreed with we would get cookies when you continue to see this website.
Education and Training
intellim provides Oncology Training
for your CRAs and R&D staffs
intellim provides Oncology Training to your CRAs and R&D staffs, which is conducted based on the training materials for our unique training curriculum, "Oncology Specialist & Expert Accreditation Program"
(1) Basic training in Oncology
(2) Advanced training in Oncology
i) Molecular Targeted Drug
ii) Individual Cancer Advanced Education & Training (including RECIST & CTCAE practice)
Our Services
(1)Basic Training in Oncology
This training program is suitable for CRAs, Clinical Development staff members and MR who are not experienced in Oncology.Total 130 CRAs and R&D staffs from 5 companies have completed this training.
Curricula
I . Basic of Cancer
What is Cancer?
Epidemiology of Cancer
Carcinogenic Factors
Proliferation, Invasion, Metastasis of Cancer
Cancer and Angiogenesis
Cancer Diagnosis
Staging Classification of Cancer
Cancer Treatment
II . Basic of Anti-cancer Drug Therapy
Purpose of Anti-Cancer Chemotherapy
Multi Drug Combination Therapy
Regimen
Cancer Treatment Guideline
RECIST Guidelines
RECIST Case study
Analysis of Survival Time
Endpoint
Forest plot, Waterfall plot
III . Cytotoxic Anti-Cancer Agents
What is Cytotoxic Anti-Cancer Agents?
Alkylating Agents
Platinum Agents
Anti-Cancer Antibiotics
Antimetabolites
Topoisomelase Inhibitor
Microtubule Inhibitors
IV . Molecular Targeted Agents
Molecular Targeted Agents
Signaling
What is Antibody drug?
Anti-HER2 antibody drug
Anti-VEGF antibody drug
Anti-EGFR antibody drug
Antibody drug against antigen on the cell surface
Small Molecular Agents
ABL tyrosine-kinase inhibitor
EGFR tyrosine-kinase inhibitor
ALK fusion protein tyrosine-kinase inhibitor
EGFR・HER2 tyrosine-kinase inhibitor
Multi-kinase inhibitor
mTOR inhibitor
Proteasome inhibitor
Other Small Molecular Agents
V . Hormone Therapy Agents
What is Hormone Therapy?
Breast Cancer drugs
Prostate Cancer drugs
VI . Anti-Cancer Agents and Adverse Events
What is CTCAE?
Major Adverse Reaction of Anti-Cancer Agents
Hematotoxicity
Gastrointestinal Toxicity
Skin Toxicity
Pulmonary Toxicity
Cardiac Toxicity
Renal Toxicity
Neurology Toxicity
Infusion reaction
(2)Advanced training in Oncology
i) Molecular Targeted Drug
This training program is suitable for CRAs, clinical development staff members and MR who are not experienced in Molecular Targeted Agents. They can learn from basic of Molecular Targeted Agents, its development trend and the latest update.Total 30 CRAs and R&D staffs have completed this training.
Curricula
I . Biological Characteristic of Cancer
Cell Cycle
Signaling
Oncogene
Cancer and Angiogenesis
Molecular Diagnosis
II . Molecular Targeted Agents (Pharmacology, EBM, adverse events, development trend)
What is Molecular Targeted Agents?
What is Antibody Drug?
Anti-HER2 antibody drug
Anti-VEGF antibody drug
Anti-EGFR antibody drug
Other Antibody drug against antigen on the cell surface
Small Molecular Agents
ABL tyrosine-kinase inhibitor
EGFR tyrosine-kinase inhibitor
ALK fusion protein tyrosine-kinase inhibitor
EGFR・HER2 tyrosine-kinase inhibitor
Multi-kinase inhibitor
mTOR inhibitor
Proteasome inhibitor
Other Small Molecular Agents
ii) Individual Cancer Advanced Education & Training (including RECIST & CTCAE practice)
CRAs and clinical development staff members can learn characteristics of Cancers suitable for clinical trials and advanced skills of RECIST and CTCAE for monitoring practices. Total 60 CRAs and R&D staffs from 3 companies have completed this training.
Curricula
I . Training by Cancer type
Epidemiology
Clinical condition
Diagnosis and Examination
Classification
Treatment
II . Practice of RECIST and CTCAE by Cancer type
Evaluation of Efficacy
About RECIST1.1
Case Study
Evaluation of Safety
About NCI-CTCAE
Case Study
Points of attention at Monitoring
Important points at SDV
For more information
If you have any comments, questions, please contact us.
To submit a more detailed RFI,
please contact us here.
Oncology Training Services
